WallStSmart
IINN

Inspira Technologies Oxy BHN Ltd

NASDAQ: IINN · HEALTHCARE · MEDICAL DEVICES

$0.40
-9.05% today

Updated 2026-06-03

Market cap
$18.91M
P/E ratio
P/S ratio
65.43x
EPS (TTM)
$-0.45
Dividend yield
52W range
$0 – $2
Volume
27.8M

Inspira Technologies Oxy BHN Ltd (IINN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$4800.00$-1.11M$-1.88M$-7.88M$-7.38M$-9.76M$-9.37M$-9.86M
Capital expenditures$31000.00$31000.00$23000.00$176000.00$304000.00$206000.00$164000.00$103000.00
Depreciation
Stock-based comp$3.29M$3.90M$6.70M$4.88M$1.49M$1.89M$3.58M
Free cash flow$-26200.00$-1.14M$-1.90M$-8.05M$-7.68M$-9.96M$-9.54M$-9.96M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Inspira Technologies Oxy BHN Ltd's revenue?

Inspira Technologies Oxy BHN Ltd's trailing twelve-month revenue is $289000.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is IINN?

In its most recent fiscal year, IINN ran a gross margin of -94.12%, an operating margin of -4,710.73%, and a net margin of -4,574.39%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does IINN generate?

IINN produced $-9.96M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.